GLP-1, a hormone linked to metabolism, has become a hot topic. Originally a term from medical studies, it's now widely discussed, especially with the rise of medications that target it. Recently, there's growing interest in how gut health might play a role in GLP-1 production. This has led to probio
Obesity drugs like Ozempic and Wegovy are game-changers. They help people shed pounds faster than diet and exercise alone. But quitting these meds can lead to quick weight regain. Research from the University of Oxford found that people who stop GLP-1 drugs often gain back almost a pound every month
In 2025, several well-known figures shared their weight loss stories. These stories highlight the challenges and triumphs of managing weight, often with the help of medications like GLP-1 drugs. Oprah Winfrey, the famous talk show host, spoke openly about her health journey. She started taking GLP-
People are talking about how weight-loss drugs like Ozempic and Zepbound are changing lives. These drugs do more than just help with weight. They can also shake up relationships. One couple's story shows how these drugs can cause big changes. The wife started taking Ozempic. She lost weight and fel
People often wonder if combining medication with lifestyle changes is the best way to manage health conditions. One area of interest is the use of GLP-1 receptor agonists along with lifestyle modifications. These medications are commonly used to manage type 2 diabetes and obesity. They work by mimic
Novo Nordisk has introduced a new pricing strategy for its weight-loss drugs, Ozempic and Wegovy. Starting now, people without insurance can buy the lowest doses for $199 a month for two months. After that, the price jumps to $349. This deal is available through the drugs' websites and select pharma
Andy Richter, known for his work in late-night TV, recently shared his honest thoughts on his weight-loss journey. He didn't shy away from talking about using GLP-1 medications to help him shed pounds while competing on Dancing with the Stars. Richter, now 59, openly discussed his decision to use th
Two biotech startups, RenBio and Fractyl Health, are exploring innovative ways to help the body produce more GLP-1, a hormone that plays a crucial role in regulating appetite and blood sugar levels. Their goal is to develop gene therapies that can turn cells into tiny factories producing GLP-1, pote
More and more people are using weight loss drugs through their jobs. But these drugs are expensive. This is causing big problems for employers. Big companies are more likely to cover these drugs. 43% of large firms now offer this benefit. That's up from 28% last year. But smaller companies are not
Employers are bracing for a significant hike in health care costs next year, with a median increase of 9 percent expected. This trend is largely driven by the rising use of GLP-1 drugs for obesity and diabetes, as well as the increasing prevalence and cost of cancer treatments. The survey, which inc
